Orthofix International | OFIX - Selling And Administration Expenses


Orthofix International reported $130.35M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Accuray USD 127.32M 500.16M Sep/2025
AngioDynamics USD 36.57M 3.79M Sep/2025
Artivion USD 55.75M 4.54M Dec/2025
AtriCure USD 78.34M 109K Dec/2025
Dexcom USD 349.7M 49.8M Mar/2026
EDAP TMS EUR 8.81M 1.57M Sep/2025
Globus Medical USD 318.48M 4.88M Dec/2025
Inogen USD 43.77M 510K Jun/2024
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
J&J USD 6.03B 719M Mar/2026
Medtronic 2.97B 159M Sep/2025
Mesa Laboratories USD 27.31M 380K Sep/2024
Orthofix International USD 130.35M 11.31M Dec/2025
Plus Therapeutics USD 3.49M 559K Dec/2025
Smith & Nephew USD 1.42B 65M Dec/2025
STAAR Surgical USD 38.94M 20.44M Dec/2025
Stryker USD 2.15B 17M Mar/2026
Surmodics USD 11.4M 3.18M Jun/2025
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 222.37M 59.4M Dec/2025
Veracyte USD 43.31M 8.43M Dec/2025
Zimmer Biomet Holdings USD 849.9M 5.8M Mar/2026